Elena Nikulina

U.S. loses measles-free status as outbreaks intensify nationwide

U.S. loses measles-free status as outbreaks intensify nationwide
Measles returns to U.S.

More than 25 years after eliminating measles, the U.S. now regains endemic transmission status following a year of uninterrupted spread. The designation comes as reported infections top 5,400 nationwide in 2026 and deaths linked to the disease reach 10 across three states.

Highlights

  • The U.S. loses official measles elimination status after 12 months of continuous transmission, joining Canada, Spain, and the UK with recent WHO reviews.
  • Measles-related deaths in 2026 total 10 nationwide, with all known fatalities occurring among unvaccinated individuals and most cases concentrated in Pennsylvania.
  • CDC reports MMR vaccination coverage for kindergarteners drops to 92.4% in 2025-2026, below the 95% threshold, while annual outbreak-related costs reach nearly $83 million.

PAHO decision follows 12 months of transmission

As reported by CNBC, citing Pan American Health Organization, the U.S. loses its official measles elimination designation after 12 months of continuous transmission and a review by an independent panel of eight scientific experts convened last week. The final determination is made by PAHO's director, who concludes measles is now endemic in the country, meaning the virus is once again spreading regularly and sustaining outbreaks.

The change marks a major reversal for public health authorities as declining childhood immunization rates and persistent vaccine hesitancy continue to support fresh outbreaks. Among the reported deaths for which vaccination status is available, all are unvaccinated.

States have confirmed 10 deaths associated with measles so far in 2026, including seven in Pennsylvania, one in New York and two in Wisconsin. The U.S. also joins Canada, Spain and the UK, which have recently lost measles-free status after review by World Health Organization experts.

Vaccination gaps raise health and economic pressure

The new designation adds pressure on the Trump administration and Health and Human Services Secretary Robert F. Kennedy Jr., who has moved to change recommendations for the childhood measles, mumps and rubella vaccine and has a long record of questioning its safety without evidence. Even so, the Centers for Disease Control and Prevention signals no shift in outbreak response, with Director Dr. Erica Schwartz saying last week that the agency plans to keep emphasizing MMR vaccination and coordination with states.

Public health specialists say the resurgence reflects lower vaccination coverage among children. CDC data shows MMR coverage among U.S. kindergarteners falls to 92.4% in the 2025-2026 school year, below the 95% level generally recommended to prevent sustained transmission; the vaccine is about 97% effective after two doses and 93% effective after one dose.

The outbreaks are also creating a sizable cost for the healthcare system. Based on this year's caseload, a Johns Hopkins University research tool estimates the economic burden at nearly $83 million, including $56 million in public health response costs, almost $25 million in lost productivity and more than $1.8 million in direct medical expenses.

This adds to earlier discussion around Malaysia’s planned National Health Fund legislation by 2029 to restructure healthcare financing.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.